A GLP-1 weight loss timeline maps out expected month-by-month progress on medications like Ozempic, Wegovy, Mounjaro, and Zepbound. Weight loss accelerates gradually as doses escalate over 4–6 months, then plateaus near peak effect around month 12–18. Based on averages from the STEP (semaglutide) and SURMOUNT (tirzepatide) clinical trials.
Your Medication & Starting Weight
Enter your weight to see a personalized projection
Individual results vary significantly
Projected Weight Loss Curve
Based on clinical trial averages — individual results vary
Month-by-Month Timeline
| Month | Dose | Cumulative Loss | Current Weight | % Body Weight | What to Expect |
|---|
Dose Escalation Schedule
Standard escalation — your prescriber may adjust timing based on tolerance
Side Effects Timeline
Important Medical Disclaimer
Individual results vary significantly. This timeline shows averages from clinical trials (STEP trials for semaglutide, SURMOUNT trials for tirzepatide). Actual weight loss depends on diet, exercise, metabolic factors, dose tolerance, and medication adherence. Consult your healthcare provider before starting or changing any medication regimen.
How to Use the GLP-1 Weight Loss Timeline
This GLP-1 weight loss timeline translates clinical trial data into a personalized month-by-month projection for your starting weight. Rather than guessing what to expect from Ozempic, Wegovy, Mounjaro, or Zepbound, you can see the expected curve based on the same data your prescriber references — the landmark STEP and SURMOUNT trials.
Step 1: Select Your Medication
Choose between Semaglutide (Ozempic or Wegovy) and Tirzepatide (Mounjaro or Zepbound). While Ozempic and Wegovy both contain semaglutide, Wegovy is specifically FDA-approved for weight loss and reaches a higher maintenance dose (2.4mg vs. 2.0mg for Ozempic). Tirzepatide is a dual GIP/GLP-1 agonist that generally produces greater weight loss on average — SURMOUNT-1 showed 20–22% average body weight loss at the 15mg dose versus ~15% for semaglutide.
Step 2: Enter Your Starting Weight
Type in your current weight in lbs or kg using the unit toggle. The tool scales all projections — both absolute pound/kg losses and percentage of body weight — to your specific starting weight. Heavier starting weights typically result in larger absolute losses even when the percentage is similar, since 15% of 300 lbs is 45 lbs versus 22.5 lbs at 150 lbs.
Step 3: Build Your Timeline
Click "Build My Weight Loss Timeline" to generate the full month-by-month projection. You'll see a visual weight loss curve, a detailed monthly table with expected dose at each stage, and a side-effects timeline. The adherence selector lets you model conservative, average, or high-responder outcomes — useful for setting realistic expectations.
Understanding the Dose Escalation Schedule
GLP-1 medications use a deliberate slow-start protocol to minimize side effects. Semaglutide begins at 0.25mg weekly for 4 weeks, then escalates every 4 weeks through 0.5mg, 1.0mg, 1.7mg, and finally 2.4mg. Tirzepatide starts at 2.5mg weekly and increases by 2.5mg every 4 weeks, reaching the maximum 15mg dose after about 5–6 months. The dose escalation schedule isn't just a protocol — the weight loss accelerates meaningfully with each dose increase, which is why the steepest portion of the weight loss curve typically falls between months 2–9.
What the Clinical Trials Tell Us
The STEP 1 trial (68 weeks, 2.4mg semaglutide) found average weight loss of 14.9% of body weight compared to 2.4% for placebo. The SURMOUNT-1 trial (72 weeks, 15mg tirzepatide) found average weight loss of 20.9% at the highest dose. These are averages — roughly one third of patients are "high responders" who lose considerably more, and a portion see more modest results. Consistent medication use, reduced caloric intake, and regular physical activity all improve outcomes beyond the clinical trial averages.
Managing Side Effects Over Time
Nausea is the most commonly reported side effect, affecting up to 40–50% of patients in the first month. The good news is that GI symptoms typically peak during dose increases and improve substantially once you stabilize at a dose. Most patients report minimal side effects by months 3–4. If nausea persists, your prescriber can slow the escalation schedule — some patients take 8 weeks at each dose level instead of 4, which is equally effective over a longer timeline.
Frequently Asked Questions
How fast do you lose weight on Ozempic?
Most people lose 2–4 lbs in the first month on Ozempic as appetite begins to decrease. By month 6, average cumulative loss is 10–20 lbs (5–10% of body weight). After 12–16 months at the full 2.4mg Wegovy dose, clinical trials show an average of ~15% total body weight loss, though individual results vary widely.
How does Mounjaro weight loss compare to Ozempic?
Tirzepatide (Mounjaro/Zepbound) consistently outperforms semaglutide in clinical trials. The SURMOUNT-1 trial showed average weight loss of 20–22% of body weight at 72 weeks on the 15mg dose, compared to ~15% for Wegovy. Tirzepatide works on two hormones (GIP and GLP-1), while semaglutide targets only GLP-1.
When will I start seeing results on a GLP-1 medication?
Most patients notice reduced appetite within the first 1–2 weeks. Visible scale changes typically begin in weeks 2–4. The most rapid weight loss usually occurs in months 2–6 as doses escalate. Progress often slows after month 9–12 as your body approaches a new set point, which is normal and expected.
What is the dose escalation schedule for Ozempic and Wegovy?
Semaglutide starts at 0.25mg weekly for 4 weeks, increases to 0.5mg, then 1.0mg. Wegovy continues escalating to 1.7mg and finally 2.4mg (the maintenance dose) over about 16–20 weeks. Ozempic typically stays at 0.5mg–2.0mg for diabetes management. Slow escalation minimizes nausea and GI side effects.
What is the dose escalation schedule for Mounjaro and Zepbound?
Tirzepatide starts at 2.5mg weekly for 4 weeks, then increases by 2.5mg every 4 weeks: 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg as the maximum dose. Reaching the top dose takes approximately 5–6 months. Not all patients need or tolerate the maximum dose — weight loss still occurs at lower doses.
Do GLP-1 side effects go away over time?
Yes, for most patients. Nausea, constipation, and reduced appetite are most intense during the first 4–8 weeks and with each dose increase. After 2–4 weeks at a stable dose, GI symptoms usually diminish significantly. Persistent or severe side effects may require slowing dose escalation or dose reduction — always consult your prescriber.
Is this timeline tool free and private?
Yes, completely free with no signup required. All calculations run locally in your browser — your weight and health data are never sent to any server. You can use it offline and your information remains entirely private.
How accurate are these weight loss projections?
Projections are based on average outcomes from the STEP clinical trials (semaglutide) and SURMOUNT trials (tirzepatide). Individual results vary significantly based on starting weight, diet, exercise, metabolic factors, and adherence. Some patients lose more than the average; others lose less. This tool shows expected averages, not guarantees.